115 related articles for article (PubMed ID: 37792315)
21. Highly Stable Silica-Coated Bismuth Nanoparticles Deliver Tumor Microenvironment-Responsive Prodrugs to Enhance Tumor-Specific Photoradiotherapy.
Xiang H; Wu Y; Zhu X; She M; An Q; Zhou R; Xu P; Zhao F; Yan L; Zhao Y
J Am Chem Soc; 2021 Aug; 143(30):11449-11461. PubMed ID: 34292717
[TBL] [Abstract][Full Text] [Related]
22. Active targeting redox-responsive mannosylated prodrug nanocolloids promote tumor recognition and cell internalization for enhanced colon cancer chemotherapy.
Gao Y; Qiu W; Liang M; Ma X; Ye M; Xue P; Kang Y; Deng J; Xu Z
Acta Biomater; 2022 Jul; 147():299-313. PubMed ID: 35640802
[TBL] [Abstract][Full Text] [Related]
23. Light-activatable dual-source ROS-responsive prodrug nanoplatform for synergistic chemo-photodynamic therapy.
Yang B; Wang K; Zhang D; Sun B; Ji B; Wei L; Li Z; Wang M; Zhang X; Zhang H; Kan Q; Luo C; Wang Y; He Z; Sun J
Biomater Sci; 2018 Nov; 6(11):2965-2975. PubMed ID: 30255178
[TBL] [Abstract][Full Text] [Related]
24. ROS-triggered cycle amplification effect: A prodrug activation nanoamplifier for tumor-specific therapy.
Huang Z; Ding Y; Luo Y; Chen M; Zeng Z; Zhang T; Sun Y; Huang Y; Zhao C
Acta Biomater; 2022 Oct; 152():367-379. PubMed ID: 36084924
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of NQO1-activated prodrugs of podophyllotoxin as antitumor agents.
Qu Y; Zhang C; Ma X; Gao Y; Liu J; Wu L
Bioorg Med Chem; 2020 Dec; 28(24):115821. PubMed ID: 33091789
[TBL] [Abstract][Full Text] [Related]
26. In vivo and in situ tracking cancer chemotherapy by highly photostable NIR fluorescent theranostic prodrug.
Wu X; Sun X; Guo Z; Tang J; Shen Y; James TD; Tian H; Zhu W
J Am Chem Soc; 2014 Mar; 136(9):3579-88. PubMed ID: 24524232
[TBL] [Abstract][Full Text] [Related]
27. Amorphous ferric oxide-coating selenium core-shell nanoparticles: a self-preservation Pt(IV) platform for multi-modal cancer therapies through hydrogen peroxide depletion-mediated anti-angiogenesis, apoptosis and ferroptosis.
Xu Z; Li Q; Zhang C; Wang P; Xu X; Ran L; Zhang L; Tian G; Zhang G
Nanoscale; 2022 Aug; 14(32):11600-11611. PubMed ID: 35861683
[TBL] [Abstract][Full Text] [Related]
28. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers.
Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H
Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983
[TBL] [Abstract][Full Text] [Related]
29. Glutathione Depletion-Induced Versatile Nanomedicine for Potentiating the Ferroptosis to Overcome Solid Tumor Radioresistance and Enhance Immunotherapy.
Song H; Sun H; He N; Xu C; Du L; Ji K; Wang J; Zhang M; Gu Y; Wang Y; Liu Q
Adv Healthc Mater; 2024 Apr; 13(9):e2303412. PubMed ID: 38245863
[TBL] [Abstract][Full Text] [Related]
30. Engineering Paclitaxel Prodrug Nanoparticles via Redox-Activatable Linkage and Effective Carriers for Enhanced Chemotherapy.
Lu S; Xia R; Wang J; Pei Q; Xie Z; Jing X
ACS Appl Mater Interfaces; 2021 Oct; 13(39):46291-46302. PubMed ID: 34558902
[TBL] [Abstract][Full Text] [Related]
31. Self-driven nanoprodrug platform with enhanced ferroptosis for synergistic photothermal-IDO immunotherapy.
Huang P; Yang Y; Wang W; Li Z; Gao N; Chen H; Zeng X
Biomaterials; 2023 Aug; 299():122157. PubMed ID: 37196407
[TBL] [Abstract][Full Text] [Related]
32. GSH-triggered release of sulfur dioxide gas to regulate redox balance for enhanced photodynamic therapy.
Zhang Y; Shen W; Zhang P; Chen L; Xiao C
Chem Commun (Camb); 2020 May; 56(42):5645-5648. PubMed ID: 32313913
[TBL] [Abstract][Full Text] [Related]
33. Glutathione and Reactive Oxygen Species Dual-Responsive Block Copolymer Prodrugs for Boosting Tumor Site-Specific Drug Release and Enhanced Antitumor Efficacy.
Yin W; Ke W; Lu N; Wang Y; Japir AAMM; Mohammed F; Wang Y; Pan Y; Ge Z
Biomacromolecules; 2020 Feb; 21(2):921-929. PubMed ID: 31961134
[TBL] [Abstract][Full Text] [Related]
34. An albumin-binding dimeric prodrug nanoparticle with long blood circulation and light-triggered drug release for chemo-photodynamic combination therapy against hypoxia-induced metastasis of lung cancer.
Luo R; Zhang Z; Han L; Xue Z; Zhang K; Liu F; Feng F; Xue J; Liu W; Qu W
Biomater Sci; 2021 May; 9(10):3718-3736. PubMed ID: 34008617
[TBL] [Abstract][Full Text] [Related]
35. Spatiotemporal Concurrent Liberation of Cytotoxins from Dual-Prodrug Nanomedicine for Synergistic Antitumor Therapy.
Zhang L; Qian M; Cui H; Zeng S; Wang J; Chen Q
ACS Appl Mater Interfaces; 2021 Feb; 13(5):6053-6068. PubMed ID: 33525873
[TBL] [Abstract][Full Text] [Related]
36. Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy.
Sun B; Chen Y; Yu H; Wang C; Zhang X; Zhao H; Chen Q; He Z; Luo C; Sun J
Acta Biomater; 2019 Jul; 92():219-228. PubMed ID: 31078764
[TBL] [Abstract][Full Text] [Related]
37. A sulfhydryl blocking reagent BT-4 sensitizes cisplatin-based micelle prodrugs for efficient treatment of breast cancer.
Lin C; Chen Y; Zhu M; Pei J; Zhou Y; Gou M; Ouyang L
Int J Pharm; 2022 Oct; 626():122187. PubMed ID: 36100145
[TBL] [Abstract][Full Text] [Related]
38. Near Infrared-Activatable Methylene Blue Polypeptide Codelivery of the NO Prodrug via π-π Stacking for Cascade Reactive Oxygen Species Amplification-Mediated Photodynamic Therapy.
Zhang Y; Zhao P; Chen X; Xu C; Guo J; Qu X; Hu X; Gao H; Huang P; Zhang J
ACS Appl Mater Interfaces; 2023 Mar; 15(10):12750-12765. PubMed ID: 36852940
[TBL] [Abstract][Full Text] [Related]
39. Thiol-Responsive Polypeptide Sulfur Dioxide Prodrug Nanoparticles for Effective Tumor Inhibition.
Zhang Y; Liu X; He P; Tang B; Xiao C; Chen X
Biomacromolecules; 2023 Sep; 24(9):4316-4327. PubMed ID: 37611178
[TBL] [Abstract][Full Text] [Related]
40. An activatable prodrug for the treatment of metastatic tumors.
Kim EJ; Bhuniya S; Lee H; Kim HM; Cheong C; Maiti S; Hong KS; Kim JS
J Am Chem Soc; 2014 Oct; 136(39):13888-94. PubMed ID: 25238144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
